Management of Parkinson's disease: Strategies, pitfalls, and future directions

Postgraduate Medicine

Volumn 110, Issue 6, 2001, Pages 15-28

  Hermanowicz, Neal ^a,b,c  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EISENHOWER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENZATROPINE MESILATE; BROMOCRIPTINE MESILATE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PERGOLIDE MESILATE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE; TRIHEXYPHENIDYL;

ABDOMINAL PAIN; AMNESIA; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; CONFUSION; CONSTIPATION; DIARRHEA; DYSKINESIA; EDEMA; EXERCISE; GENETIC ANALYSIS; HALLUCINATION; HUMAN; LIVER TOXICITY; NAUSEA; PALLIATIVE THERAPY; PARKINSON DISEASE; SOMNOLENCE; URINE RETENTION; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0035207389     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.12.1060     Document Type: Conference Paper

References (20)

1. Epidemiology and genetics of Parkinson's disease
2. Parkinson's disease: First of two parts
3. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study
4. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
5. Association of coffee and caffeine intake with the risk of Parkinson disease
6. Smoking and Parkinson's disease: A dose-response relationship
7. Parkinson disease in twins: An etiologic study
8. Familial aggregation of Parkinson's disease in Iceland
9. Mutation in the alphasynuclein gene identified in families with Parkinson's disease
10. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
11. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease
12. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease
13. A community-based study of sleep disorders in patients with Parkinson's disease
14. Risk factors for depression in Parkinson disease
15. Pramipexole vs levodopa as initial treatment for Parkinson's disease: A randomized controlled trial Parkinson's Study Group
16. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
17. Acute delirium after withdrawal of amantadine in Parkinson's disease
18. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa
19. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease
20. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain